Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Acta Physiol Hung ; 102(2): 176-88, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26100307

ABSTRACT

UNLABELLED: Periodontal inflammation is associated with morphological changes in the blood vessels which may influence the regulation of gingival blood flow (GBF). Our aim was to adapt the heat provocation test to the human gingiva to assess vascular reactivity in periodontal inflammation. METHOD: GBF was recorded by Laser Doppler Flowmetry before and after heat provocation in healthy volunteers (n = 50). Heat was generated either by warm saline or a halogen lamp. The latter method was also utilized for a heat test in non-smoking and smoking patients with periodontal inflammation. The circulatory parameters were correlated to the inflammatory marker, i.e. gingival crevicular fluid (GCF) production measured by Periotron. RESULTS: Local application of heat caused a rapid, significant and transient increase in GBF regardless of the method used. The increase in the speed and not in the concentration of moving blood cells was responsible for increased GBF. Higher GCF values were correlated with increased peak flow, flux pulse amplitude and faster restoration of GBF after the test in non-smokers, but not in smokers. CONCLUSIONS: The heat test could be a valuable tool to check the vascular reactivity of gingival vessels. Moderate periodontal inflammation may facilitate gingival vascular responsiveness which can be suppressed by smoking.


Subject(s)
Gingiva/blood supply , Hot Temperature , Microcirculation , Periodontitis/physiopathology , Smoking/adverse effects , Blood Flow Velocity , Case-Control Studies , Gingiva/metabolism , Gingival Crevicular Fluid/metabolism , Humans , Hyperemia/physiopathology , Laser-Doppler Flowmetry , Periodontitis/diagnosis , Pilot Projects , Regional Blood Flow , Severity of Illness Index , Time Factors
3.
Ophthalmologe ; 112(4): 359-63, 2015 Apr.
Article in German | MEDLINE | ID: mdl-25698591

ABSTRACT

BACKGROUND/OBJECTIVES: The aim of the study was to evaluate the volume of intraocular foreign bodies (IOFB) using computed tomography (CT) volumetry as a prognostic factor for clinical outcome in open ocular injuries. PATIENTS AND METHODS: This study compared the volume of 11 IOFBs more than 5 mm(3) in size based on CT volumetry with the real size determined by in vitro measurement. A retrospective evaluation of clinical data, visual acuity, complications and relation of size of IOFBs with clinical outcome in 33 patients (mean age 41.0 ± 13.5 years) with open ocular injuries treated at our department between January 2005 and December 2010 was carried out. RESULTS: No significant differences were found between pairwise in vitro measurement and CT volumetric size (p = 0.07). All patients were surgically treated by pars plana vitrectomy. The mean follow-up time was 7.6± 6.2 months and the mean preoperative best corrected visual acuity (BCVA) was 0.063 ± 0.16 (logMAR 1.2 ± 0.79). Postoperatively, a mean BCVA of 0.25 ± 0.2 (logMAR 0.6 ± 0.69) could be achieved. Clinical outcomes were significantly better in injuries with small IOFBs measuring < 15 mm(3) (p = 0.0098). CONCLUSIONS: The use of CT volumetry is an accurate method for measurement of IOFBs. Exact data about the size and measurement of volume are also an important factor for the prognosis of clinical outcome in open ocular injuries with IOFBs and CT volumetry can also provide important information about the localization of IOFBs.


Subject(s)
Cone-Beam Computed Tomography/standards , Eye Foreign Bodies/diagnosis , Eye Injuries, Penetrating/diagnosis , Visual Acuity , Vitrectomy , Adolescent , Adult , Aged , Eye Foreign Bodies/complications , Eye Foreign Bodies/surgery , Eye Injuries, Penetrating/surgery , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Treatment Outcome , Young Adult
4.
J Periodontal Res ; 48(2): 194-202, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22957787

ABSTRACT

OBJECTIVE: The aim of the present study was to investigate the possible microvascular regulatory role of vascular endothelial growth factor receptor type 2 (VEGFR2) in experimental gingivitis in rats. BACKGROUND: Our previous results demonstrated that functionally active VEGFR2s are located in the venules of rat gingiva. While there is no remarkable endogenous gingival VEGF production under normal circumstances, exogenous VEGF, via VEGFR2, shows venodilatory effects. We assumed that VEGF plays an important role in vasoregulatory processes (vasodilation, increased permeability, angiogenesis) of gingival inflammation. METHODS: Gingivitis was induced by placing ligatures and composite material around and between the lower incisors of anesthetized Wistar rats next to the gingival margin. Seven days later, VEGFR2 antagonist (ZM323881), was dripped upon the labial gingiva next to the lower incisors. Diameter changes of the selected gingival venules were measured by vital microscopy. Animals with healthy gingiva served as controls. Venule diameter changes were compared to the baseline and to control groups (no ligature). Immunohistochemical and Western blot analysis for VEGFR2 were utilized. RESULTS: After 15, 30 and 60 min of local application of ZM323881, there was a significant venoconstriction in the inflamed gingiva compared to the baseline, while no change was recorded in controls. Endothelium, smooth muscle cells and pericytes of the gingivitis group showed increased VEGFR2 expression. CONCLUSION: Our findings suggest that there is an increased VEGF production in gingivitis, which may play an important role in vasodilation of rat gingival venules.


Subject(s)
Gingivitis/pathology , Vascular Endothelial Growth Factor Receptor-2/analysis , Venules/pathology , Animals , Capillary Permeability/drug effects , Endothelium, Vascular/drug effects , Endothelium, Vascular/pathology , Gingiva/blood supply , Male , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/pathology , Neovascularization, Pathologic/chemically induced , Pericytes/drug effects , Pericytes/pathology , Quinazolines/pharmacology , Random Allocation , Rats , Rats, Wistar , Time Factors , Vascular Endothelial Growth Factor A/pharmacology , Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors , Vascular Endothelial Growth Factor Receptor-2/physiology , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology , Venules/drug effects , Venules/physiology
5.
J Physiol Pharmacol ; 60 Suppl 7: 115-22, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20388954

ABSTRACT

The pentadecapeptide BPC 157 has been shown to have anti-inflammatory and wound healing effects on multiple target tissues and organs. The purpose of the present study was to investigate the effect of BPC 157 on inflammation and bone resorption in experimental periodontitis in rats. First the acute effect of BPC was tested on gingival blood flow by laser doppler flowmetry. Then periodontitis was produced by a silk ligature placed around the lower left first molar. Rats were treated with BPC 157 (once daily for 12 days) or vehicle. At day 13, the gingivomucosal tissues encircling the molars were removed on both sides. Inflammation was assessed by Evans blue plasma extravasation technique and by histology. Alveolar bone loss was analyzed by microCT. BPC 157 had no effect on gingivomucosal blood flow. Twelve day ligature caused a significantly increased Evans blue extravasation in the gingivomucosal tissue, histological signs of inflammation, and alveolar bone destruction. BPC 157 treatment significantly reduced both plasma extravasation, histological alterations and alveolar bone resorption. In conclusion, systemic application of BPC 157 does not alter blood circulation in healthy gingiva. Chronic application of the peptide has potent antiinflammatory effects on periodontal tissues in ligature induced periodontitis in rats. Taken together, this proof of concept study suggests that BPC 157 may represent a new peptide candidate in the treatment of periodontal disease.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Peptide Fragments/therapeutic use , Periodontitis/prevention & control , Proteins/therapeutic use , Alveolar Bone Loss/prevention & control , Animals , Bone Resorption/diagnostic imaging , Bone Resorption/prevention & control , Capillary Permeability/drug effects , Gingiva/blood supply , Gingiva/drug effects , Gingiva/pathology , Gingivitis/pathology , Gingivitis/prevention & control , Hemodynamics/drug effects , Imaging, Three-Dimensional , Laser-Doppler Flowmetry , Male , Mandible , Molar , Rats , Rats, Wistar , X-Ray Microtomography
6.
Life Sci ; 77(12): 1367-74, 2005 Aug 05.
Article in English | MEDLINE | ID: mdl-15893775

ABSTRACT

Local application of dental bond materials can cause pulpal vasodilation and hyperemia. Such local hemodynamic changes may be mediated by alterations in the levels of locally generated nitric oxide (NO). In different species systemic administration of NO synthase inhibitors leads to a decrease in pulpal blood flow. In contrast, the local administration of these inhibitors has not been tested yet. Therefore, the effect of locally blocked NO synthase on the internal diameter of rat pulpal arterioles under basal conditions and immediately after dental bond material application was studied by using vitalmicroscopic technique. The NO synthase blocker (L-NAME) was locally administered on a thinned dentine layer of the left lower incisor. L-NAME reduced the diameter of the pulpal arteriole both in basal and after bond material-induced hyperaemic conditions. These data suggest that the local formation of NO may have a significant role in the acute vasodilation induced by bond material application and also in maintenance of basal pulpal arteriolar tone.


Subject(s)
Dental Bonding , Dental Materials/pharmacology , Dental Pulp/blood supply , Enzyme Inhibitors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Vasodilation/drug effects , Animals , Arterioles/anatomy & histology , Arterioles/drug effects , Dose-Response Relationship, Drug , Male , NG-Nitroarginine Methyl Ester/pharmacology , Rats , Rats, Sprague-Dawley , Regional Blood Flow/drug effects
7.
J Dent Res ; 83(4): 312-6, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15044505

ABSTRACT

Nitric oxide synthase (NOS) plays a significant role in the pathogenesis of pulpitis. In this study, we hypothesized the existence of endothelial (eNOS) and inducible (iNOS) enzyme isoforms in human dental pulp. Extracted third molar pulps were divided into groups based on clinical diagnosis: healthy, hyperemic, and irreversible pulpitis. We have localized the eNOS and iNOS by immunohistochemistry and have tested their mRNA expression by RT-PCR and protein levels by Western blots. eNOS is present in the endothelial cells and odontoblasts of the healthy pulp, but an elevation of eNOS mRNA and protein levels with a concomitant dilation of vessels was characteristic under pathological conditions. Healthy pulp tissue failed to exhibit any iNOS; however, acute inflammation enhanced the mRNA and protein levels of iNOS, mainly in the leukocytes. There are differences in localization and expression between eNOS and iNOS in healthy and inflamed dental pulp.


Subject(s)
Dental Pulp/enzymology , Hyperemia/enzymology , Nitric Oxide Synthase/metabolism , Pulpitis/enzymology , Adult , Dental Pulp/cytology , Dental Pulp/pathology , Endothelial Cells/enzymology , Endothelial Cells/pathology , Humans , Hyperemia/pathology , Image Processing, Computer-Assisted , In Vitro Techniques , Inflammation/enzymology , Isoenzymes/metabolism , Molar, Third/enzymology , Molar, Third/pathology , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , Odontoblasts/enzymology , Odontoblasts/pathology , Pulpitis/pathology , RNA, Messenger/analysis , Reference Values , Vasodilation/physiology
8.
J Dent Res ; 82(12): 987-92, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14630900

ABSTRACT

We have investigated the role of the activation of nuclear poly(ADP-ribose) polymerase (PARP) enzyme, a mediator of downstream nitric oxide toxicity, using a combined approach of pharmacological inhibition and genetic disruption in a ligature-induced-periodontitis model in rats and mice. Immunohistochemical analysis revealed significantly increased poly(ADP-ribose) nuclear staining (indicative of PARP activation) in the subepithelial connective tissue of the ligated side compared with the non-ligated side. Ligation-induced periodontitis resulted in marked plasma extravasation in the gingivomucosal tissue and led to alveolar bone destruction compared with the non-ligated side, as measured by the Evans blue technique and by videomicroscopy, respectively. PARP inhibition with PJ34, as well as genetic PARP-1 deficiency, significantly reduced the extravasation and the alveolar bone resorption of the ligated side compared with controls. Thus, PARP activation contributes to the development of periodontal injury. Inhibition of PARP may represent a novel host response modulatory approach for the therapy of periodontitis.


Subject(s)
Periodontitis/enzymology , Poly Adenosine Diphosphate Ribose/analysis , Alveolar Bone Loss/enzymology , Alveolar Bone Loss/prevention & control , Animals , Cell Nucleus/enzymology , Connective Tissue/enzymology , Disease Models, Animal , Enzyme Activation , Gingiva/enzymology , Ligation , Male , Mice , Mice, Knockout , Mouth Mucosa/enzymology , Nuclear Proteins/analysis , Periodontitis/pathology , Periodontitis/prevention & control , Phenanthrenes/pharmacology , Plasma , Poly Adenosine Diphosphate Ribose/antagonists & inhibitors , Poly Adenosine Diphosphate Ribose/deficiency , Rats , Rats, Wistar
9.
J Dent Res ; 80(2): 470-5, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11332535

ABSTRACT

An increase in nitric oxide production has been demonstrated in periodontitis. Here we investigated the potential role of nitric-oxide-derived nitrating species (such as peroxynitrite) in a rat model of ligature-induced periodontitis. Formation of 3-nitrotyrosine, the stable product formed from tyrosine reacting with nitric-oxide-derived nitrating species, was detected in the gingivomucosal tissue. 3-Nitrotyrosine immunohistochemical analysis revealed a significant elevation in the number of immunopositive leukocytes, and higher immunoreactivity of the gingival ligaments and epithelium in the ligated than in the contralateral (control) side. On both sides, several 3-nitrotyrosine-positive bands and, on the ligated side, a unique 52-kDa 3-nitrotyrosine-positive band were detected by Western blot. However, in the sterile gingivomucosal tissue of rat pups, no 3-nitrotyrosine or inducible nitric oxide synthase immunoreactivity was found. Analysis of these data suggests that resident bacteria of the gingivomucosal tissue induce an increase in reactive nitrogen species, which is greatly enhanced by plaque formation in periodontitis.


Subject(s)
Mouth Mucosa/metabolism , Nitric Oxide Synthase/biosynthesis , Nitric Oxide/biosynthesis , Periodontitis/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Animals , Blotting, Western , Enamel Organ/embryology , Enamel Organ/microbiology , Immunohistochemistry , Male , Nitric Oxide Synthase Type II , Nitro Compounds/metabolism , Rats , Rats, Wistar
10.
Life Sci ; 70(3): 279-90, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-12005261

ABSTRACT

We investigated the role of the inducible isoform of cyclooxygenase (COX-2) in a rat model of periodontitis using a selective COX-2 inhibitor NS-398. Periodontitis was produced by a silk ligature placed around the lower left 1st molar. Animals were treated with NS-398 (3 mg kg(-1) i.p., 2 times per day for 7 days) or vehicle. At Day 8, the gingivomucosal tissues encircling the mandibular 1st molars were removed on both sides for COX-2 immunohistochemistry, measurement of plasma extravasation by the Evans blue technique, and alveolar bone loss by videomicroscopy. Immunohistochemical analysis revealed numerous strongly COX-2-positive cells in the subepithelial tissues in the ligated side and only a few COX-2-reactive cells in the contralateral (control) side. Ligation significantly increased Evans blue extravasation in the gingivomucosal tissue and alveolar bone destruction compared to the control side. NS-398 treatment significantly reduced the plasma extravasation and alveolar bone resorption of the ligated side compared to vehicle administration. The present results suggest that COX-2 is induced by periodontitis, and plays an important role in gingival inflammation and alveolar bone destruction. In a previous study (Br J Pharmacol 1998;123:353-60) we found the expression of the inducible isoform of nitric oxide synthase in this model. Therefore, based on our own data and the literature, we propose that selective inhibition of these inducible enzymes might be a basis for adjunctive therapy, or new therapeutic approaches in periodontitis.


Subject(s)
Isoenzymes/biosynthesis , Periodontitis/enzymology , Prostaglandin-Endoperoxide Synthases/biosynthesis , Animals , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/therapeutic use , Immunohistochemistry , Isoenzymes/genetics , Male , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type II , Nitrobenzenes/pharmacology , Periodontitis/drug therapy , Prostaglandin-Endoperoxide Synthases/genetics , RNA, Messenger/analysis , Rats , Rats, Wistar , Sulfonamides/pharmacology
11.
J Immunol ; 164(2): 1013-9, 2000 Jan 15.
Article in English | MEDLINE | ID: mdl-10623851

ABSTRACT

Extracellular purines, including adenosine and ATP, are potent endogenous immunomodulatory molecules. Inosine, a degradation product of these purines, can reach high concentrations in the extracellular space under conditions associated with cellular metabolic stress such as inflammation or ischemia. In the present study, we investigated whether extracellular inosine can affect inflammatory/immune processes. In immunostimulated macrophages and spleen cells, inosine potently inhibited the production of the proinflammatory cytokines TNF-alpha, IL-1, IL-12, macrophage-inflammatory protein-1alpha, and IFN-gamma, but failed to alter the production of the anti-inflammatory cytokine IL-10. The effect of inosine did not require cellular uptake by nucleoside transporters and was partially reversed by blockade of adenosine A1 and A2 receptors. Inosine inhibited cytokine production by a posttranscriptional mechanism. The activity of inosine was independent of activation of the p38 and p42/p44 mitogen-activated protein kinases, the phosphorylation of the c-Jun terminal kinase, the degradation of inhibitory factor kappaB, and elevation of intracellular cAMP. Inosine suppressed proinflammatory cytokine production and mortality in a mouse endotoxemic model. Taken together, inosine has multiple anti-inflammatory effects. These findings, coupled with the fact that inosine has very low toxicity, suggest that this agent may be useful in the treatment of inflammatory/ischemic diseases.


Subject(s)
Cytokines/antagonists & inhibitors , Immunosuppressive Agents/pharmacology , Inflammation Mediators/antagonists & inhibitors , Inosine/pharmacology , Lipopolysaccharides/toxicity , Protein Processing, Post-Translational/drug effects , Shock, Septic/immunology , Shock, Septic/prevention & control , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Chemokines/antagonists & inhibitors , Chemokines/biosynthesis , Cytokines/biosynthesis , Enzyme Activation/drug effects , Enzyme Activation/immunology , I-kappa B Proteins/metabolism , Inflammation Mediators/metabolism , Injections, Intraperitoneal , Inosine/administration & dosage , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/biosynthesis , JNK Mitogen-Activated Protein Kinases , Macrophage Activation/drug effects , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/enzymology , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Male , Mice , Mice, Inbred BALB C , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/metabolism , Protein Processing, Post-Translational/immunology , Purinergic P1 Receptor Agonists , Receptors, Purinergic P1/physiology , Shock, Septic/etiology , Shock, Septic/pathology , Th1 Cells/drug effects , Th1 Cells/metabolism
12.
Life Sci ; 64(11): 953-63, 1999.
Article in English | MEDLINE | ID: mdl-10201644

ABSTRACT

The involvement of the L-arginine/NO pathway in the control of salivary fluid, amylase and epidermal growth factor (EGF) secretion was investigated in conscious rats. For the collection of saliva, an oesophageal cannula was implanted. To obtain steady secretion, submaximal carbachol background infusion was given. Different treatments included NO synthase inhibitor N(G)-nitro-L-arginine (NOLA; with or without phentolamine, propranolol), L-arginine, D-arginine and NO donor 3-morpholinosydnonimine (SIN-1) administration. Volume, amylase activity and EGF output in the secreted fluid were determined in 30 min mixed saliva samples. Carbachol infusion alone produced a modest, sustained salivary fluid and amylase secretion. NOLA (30 mg/kg) further increased both fluid (p<0.001) and amylase outputs (p<0.001). These latter effects were prevented by L-arginine but not by D-arginine or by phentolamine. Propranolol administration decreased both fluid and amylase secretion below the carbachol plateau, and NOLA did not modify this suppressed secretory rate. SIN-1 did not alter either volume or amylase secretion. Interestingly, NOLA given without carbachol did not modify salivation. Neither carbachol nor NOLA changed salivary EGF output. The present results suggest that the L-arginine/NO pathway has a modulatory role in the cholinergic control of salivary amylase secretion, but not in EGF output. The mechanisms of inhibitory action of NO on salivary fluid and amylase secretion remain to be identified.


Subject(s)
Amylases/metabolism , Epidermal Growth Factor/metabolism , Nitric Oxide/physiology , Salivary Glands/metabolism , Animals , Carbachol/pharmacology , Female , NG-Nitroarginine Methyl Ester/pharmacology , Nitroarginine/pharmacology , Rats , Rats, Wistar
13.
Br J Pharmacol ; 123(3): 353-60, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9504374

ABSTRACT

1. Excessive production of nitric oxide (NO), and the generation of peroxynitrite have been implicated in various proinflammatory conditions. In the present study, using mercaptoethylguanidine (MEG), a selective inhibitor of iNOS and a peroxynitrite scavenger, we investigated the role of iNOS and peroxynitrite in a rat model of periodontitis. 2. Periodontitis was produced in rat by a ligature of 2/0 braided silk placed around the cervix of the lower left 1st molar. Animals were then divided into two groups: one group of rats was treated with MEG (30 mg kg(-1), i.p., 4 times per day for 8 days), animals in the other group received vehicle. At day 8, the gingivomucosal tissue encircling the mandibular 1st molars was removed on both sides from ligated and sham operated animals for inducible nitric oxide synthase (iNOS) activity assay and for immunocytochemistry with anti-iNOS serum. Plasma extravasation was measured with the Evans blue technique. Alveolar bone loss was measured with a videomicroscopy. 3. Ligation caused a significant, more than 3 fold increase in the gingival iNOS activity, whereas it did not affect iNOS activity on the contralateral side, when compared to sham-operated animals. Immunohistochemical analysis revealed iNOS-positive macrophages, lymphocytes and PMNs in the connective tissue and immunoreactive layers of epithelium on side of the ligature, and only a few iNOS reactive connective tissue cells on the contralateral side [corrected]. Ligation significantly increased Evans blue extravasation in gingivomucosal tissue and alveolar bone destruction compared to the contralateral side. MEG treatment significantly reduced the plasma extravasation and bone destruction. 4. The present results demonstrated that ligature-induced periodontitis increases local NO production and that MEG treatment protects against the associated extravasation and bone destruction. Based on the present data, we propose that enhanced formation of NO and peroxynitrite plays a significant role in the pathogenesis of periodontitis.


Subject(s)
Enzyme Inhibitors/pharmacology , Guanidines/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Periodontitis/drug therapy , Animals , Capillary Permeability/drug effects , Disease Models, Animal , Enzyme Inhibitors/therapeutic use , Free Radical Scavengers/pharmacology , Guanidines/therapeutic use , Immunohistochemistry , Lipopolysaccharides/pharmacology , Male , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Periodontitis/enzymology , Periodontitis/physiopathology , Rats , Rats, Wistar
14.
Neurosci Lett ; 227(2): 91-4, 1997 May 16.
Article in English | MEDLINE | ID: mdl-9180211

ABSTRACT

In a previous study we found that nitric oxide (NO) plays an essential role in the hemodynamic regulation of the feline dental pulp. However, no evidence for the presence of nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) containing nerve fibers was found in the rat and cat dental pulps. In the present study, we are first to report the presence of a small number of NADPH-d positive and/or NO synthase immunoreactive perivascular and solitary varicose axons in the dental pulp and abundant number of similar axons in the gingiva of cats and dogs. These fibres may travel within the inferior alveolar nerve and might participate in sensory (i.e. pain) as well as in autonomic (i.e. regulation of blood flow) innervation of the dental pulp and gingiva.


Subject(s)
Dental Pulp/enzymology , Gingiva/enzymology , Nerve Fibers/physiology , Nitric Oxide Synthase/metabolism , Animals , Cats , Dogs , Female , Male , Nerve Fibers/enzymology
15.
J Physiol Paris ; 91(3-5): 217-21, 1997.
Article in English | MEDLINE | ID: mdl-9403798

ABSTRACT

In a recent study we have demonstrated the presence of nitric oxide synthase immunoreactive neurons and also perivascular, periacinar and periductal nerve fibres in feline submandibular salivary gland. The role of nitric oxide (NO) in salivary vasoregulation has been suggested by other data too, but the effect of NO on salivary amylase secretion has not been investigated yet. Under ether anaesthesia a catheter was introduced into the oesophagus for salivary juice collections, and a cannula was inserted into the jugular vein for infusions. After postanaesthesia recovery, submaximal carbachol infusion was given as a background to obtain steady secretion because of the low basal secretory rate. Then different groups of animals received NO synthase inhibitor NOLA (NG-nitro-L-arginine), L-arginine, D-arginine or NO donor SIN-1 (3-morpholinosydnonimine). Volume and amylase activity were determined in mixed saliva samples collected for 30 min. Carbachol background infusion alone induced an elevated, sustained salivary secretion. NOLA (30 mg/kg) increased both volume and amylase output (P < 0.001). This effect was prevented by L-arginine but not by D-arginine. SIN-1 did not change either volume or amylase secretion. The present results suggest that the L-arginine/NO pathway has a modulatory effect on salivary fluid and amylase secretion, which is probably not related to its effect on salivary blood flow. NO may block certain presently unidentified secretagogue mechanisms and/or may relax myoepithelial cells.


Subject(s)
Amylases/metabolism , Arginine/metabolism , Nitric Oxide/metabolism , Saliva/enzymology , Amylases/antagonists & inhibitors , Animals , Carbachol/pharmacology , Enzyme Inhibitors/pharmacology , Female , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , Muscarinic Agonists/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Rats , Rats, Wistar , Saliva/metabolism , Salivation/drug effects
16.
Arch Oral Biol ; 41(7): 699-704, 1996 Jul.
Article in English | MEDLINE | ID: mdl-9015572

ABSTRACT

The aim was to examine whether (1) blood flow and vascular resistance are altered in response to exogenous nitric oxide and (2) whether endogenous synthesis of nitric oxide participates in the haemodynamic regulation of the submandibular, parotid and pancreatic glands. Experiments were performed on anaesthetized, artificially ventilated cats. Mean arterial blood pressure, heart rate, blood gases, cardiac output and tissue blood flow were determined before and 15 min after intravenous administration of either the nitric oxide donor SIN-1 (3-morpholinosydnonimine, 1 mg/kg, n = 10) or the competitive nitric oxide synthase inhibitor NOLA (NG-nitro-L-arginine, 30 mg/kg, n = 9) blood flow was measured by a radioactive-labelled microsphere method. In the SIN-1 group, in spite of a serious decrease in mean arterial blood pressure (p < 0.001), the blood flow in the glands remained unchanged. The vascular resistance decreased after SIN-1 in the submandibular and pancreatic glands (p < 0.001 and p < 0.05, respectively), and was slightly reduced in the parotid. The NOLA increased mean arterial blood pressure (p < 0.01) and reduced the blood flow in the submandibular and pancreatic glands (p < 0.01 and p < 0.001, respectively), but the decrease in the parotid was not significant. Vascular resistance increased after NOLA in all three glands (p < 0.05, p < 0.001 and p < 0.05). These findings suggest that basal nitric oxide production in these exocrine glands is sufficient to modulate vascular resistance. Moreover, the release of endogenous NO from the nerves and/or endothelium is probably involved in the regulation of vascular tone. The nitric oxide-dependent component of blood-flow regulation, however, seems to be less pronounced in the parotid gland.


Subject(s)
Exocrine Glands/blood supply , Hemodynamics/drug effects , Nitric Oxide Synthase/metabolism , Nitric Oxide/physiology , Animals , Blood Flow Velocity/drug effects , Blood Pressure/drug effects , Cats , Endothelium, Vascular/enzymology , Endothelium, Vascular/innervation , Enzyme Inhibitors/pharmacology , Exocrine Glands/enzymology , Male , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , Nerve Fibers/metabolism , Nitric Oxide/biosynthesis , Nitric Oxide/pharmacology , Nitric Oxide Synthase/analysis , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Pancreas/blood supply , Pancreas/enzymology , Parotid Gland/blood supply , Parotid Gland/enzymology , Regional Blood Flow/drug effects , Submandibular Gland/blood supply , Submandibular Gland/enzymology , Vascular Resistance/drug effects , Vasodilator Agents/pharmacology
17.
J Dent Res ; 74(8): 1501-6, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7560406

ABSTRACT

Many authors have studied the hemodynamics of the dental pulp; however, there are scarcely any data regarding the involvement of the L-arginine/nitric oxide pathway in the regulatory mechanism. Thus, we have examined the physiological effects of (1) NG-nitro-L-arginine as an inhibitor of nitric oxide synthesis and (2) the nitric oxide donor 3-morpholinosydnonimine on blood flow and vascular resistance in the canines of anesthetized cats to study the potential involvement of nitric oxide in the regulation of dental vascular homeostasis. Mean arterial blood pressure, heart rate, blood gases, pH, cardiac output, and tissue blood flow were determined prior to and 15 min after i.v. administration of either NG-nitro-L-arginine (30 mg/kg, n = 9) or 3-morpholinosydnonimine (1 mg/kg, n = 7). Blood flow was measured by radioactive-labeled microspheres. There were no significant differences in baseline parameters between the two groups of cats. The dental pulp blood flow decreased to 53 +/- 13% (p < 0.01) of the control level after NG-nitro-L-arginine administration, while it decreased only slightly (to 82 +/- 12%) after 3-morpholinosydnonimine administration. The dental pulp's vascular resistance increased to 367 +/- 69% (p < 0.01) of the control level after NG-nitro-L-arginine, while it decreased to 73 +/- 10% (p < 0.05) of control after 3-morpholinosydnonimine. We found that the L-arginine/nitric oxide pathway plays an important role in the regulation of pulpal blood circulation.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Dental Pulp/blood supply , Nitric Oxide/physiology , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Arginine/physiology , Blood Pressure/drug effects , Cardiac Output/drug effects , Cats , Cuspid , Enzyme Inhibitors/pharmacology , Heart Rate/drug effects , Homeostasis , Male , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , NG-Nitroarginine Methyl Ester , Nitric Oxide/antagonists & inhibitors , Nitric Oxide Synthase/antagonists & inhibitors , Oxygen/blood , Regional Blood Flow , Vascular Resistance/drug effects , Vasodilator Agents/pharmacology
18.
Neurosci Lett ; 192(1): 9-12, 1995 Jun 02.
Article in English | MEDLINE | ID: mdl-7545801

ABSTRACT

Combined nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) histochemistry and nitric oxide synthase (NOS) immunocytochemistry were used to study the distribution of nitric oxide synthesizing elements in the cat submandibular gland. A large number of thin varicose fibres, with intense staining for both markers, were seen around or in close contact with the acini. Some of the stained nerve fibres were associated with intra- and interlobular salivary ducts and blood vessels. All neurones in the submandibular ganglia showed intense staining for both NADPH-d and NOS. The epithelial layer of the salivary ductal branches and the endothelial lining of blood vessels were NOS immunonegative but NADPH-d positive. Our results suggest that NO might act as a neurotransmitter in the regulation of blood flow and secretion in the submandibular salivary gland.


Subject(s)
Amino Acid Oxidoreductases/metabolism , NADPH Dehydrogenase/metabolism , Submandibular Gland/enzymology , Animals , Cats , Female , Immunohistochemistry , Male , NADPH Dehydrogenase/analysis , Nitric Oxide Synthase , Tissue Distribution
20.
Circ Shock ; 36(3): 238-41, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1611708

ABSTRACT

The effect of hemorrhagic shock on the vasodilatory responses of the feline renal artery was studied in vitro. In sodium pentobarbital anaesthetized cats, a steady level of hypotension (50 mm Hg) was reached by bleeding into a reservoir and maintained at this level by further bleeding or autotransfusion for 2 hr (shock). One to 3 mm long rings of the arteries (from control and shocked animals) were suspended for isometric tension recording in organ chambers filled with modified Krebs-Henseleit solution, aerated with 95% O2-5% CO2 at 37 degrees C. The experiments were performed in the presence of indomethacin and propranolol to inhibit cyclooxygenase activity and beta-adrenoceptors, respectively. Endothelium-dependent relaxations induced by acetylcholine and ATP were significantly inhibited in the vessels after hemorrhagic shock. In contrast, endothelium-independent vasodilation induced by adenosine remained unchanged after this shock state. The present results suggest a marked and selective impairment of the endothelial function of the renal artery of hemorrhagic shock. This alteration of the renovascular reactivity might play an important role in the development of vasoconstriction in the renal vasculature during and after this hemorrhagic shock state.


Subject(s)
Acetylcholine/pharmacology , Adenosine Triphosphate/pharmacology , Endothelium, Vascular/drug effects , Renal Artery/drug effects , Shock, Hemorrhagic/physiopathology , Vasodilation/drug effects , Adenosine/pharmacology , Animals , Cats , Endothelium, Vascular/physiopathology , Female , In Vitro Techniques , Male , Nitric Oxide/physiology , Renal Artery/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...